BR100 Increased By (0.29%)
BR30 Increased By (0.37%)
KSE100 Increased By (0.07%)
KSE30 Increased By (0.23%)
AGHA 7.75 Decreased By ▼ -0.17 (-2.15%)
BECO 5.20 No Change ▼ 0.00 (0%)
BML 58.30 Decreased By ▼ -0.95 (-1.6%)
BOP 33.95 Increased By ▲ 0.27 (0.8%)
CNERGY 10.63 Increased By ▲ 0.82 (8.36%)
CSIL 5.30 Decreased By ▼ -0.12 (-2.21%)
FCCL 53.75 Increased By ▲ 0.23 (0.43%)
FFL 16.50 Decreased By ▼ -0.18 (-1.08%)
FNEL 1.24 Increased By ▲ 0.03 (2.48%)
KEL 7.30 Decreased By ▼ -0.05 (-0.68%)
KOSM 5.61 No Change ▼ 0.00 (0%)
LOTCHEM 29.87 Increased By ▲ 0.76 (2.61%)
MLCF 96.30 Increased By ▲ 0.80 (0.84%)
NBP 204.40 Increased By ▲ 0.05 (0.02%)
NCPL 57.06 Decreased By ▼ -1.18 (-2.03%)
NPL 67.45 Decreased By ▼ -0.34 (-0.5%)
OGDC 317.99 Increased By ▲ 0.05 (0.02%)
PACE 10.64 Decreased By ▼ -0.07 (-0.65%)
PAEL 41.90 Increased By ▲ 0.07 (0.17%)
PIBTL 16.78 Increased By ▲ 0.28 (1.7%)
PPL 220.44 Increased By ▲ 0.70 (0.32%)
PRL 49.05 Increased By ▲ 4.46 (10%)
PTC 69.80 Decreased By ▼ -0.97 (-1.37%)
SSGC 29.26 Increased By ▲ 0.33 (1.14%)
TBL 9.78 Decreased By ▼ -0.06 (-0.61%)
TELE 8.89 Increased By ▲ 0.13 (1.48%)
TPL 17.08 Increased By ▲ 0.63 (3.83%)
TPLP 12.56 Increased By ▲ 0.46 (3.8%)
TREET 22.72 Decreased By ▼ -0.08 (-0.35%)
TRG 60.26 Increased By ▲ 0.23 (0.38%)
Business & Finance

GSK Pakistan appoints chairperson

Published Updated

Pharmaceutical giant GlaxoSmithKline Pakistan Limited announced on Tuesday the appointment of Dmytro Oliinyk, VP Head of Finance, International Region of GlaxoSmithKline, as Non-Executive Director and Chairperson.

The company disclosed in a notice to the Pakistan Stock Exchange (PSX) today.

It said that Dmytro will fill in the casual vacancy due to the resignation of Lai Kuen Goh from the Board of Directors of GlaxoSmithKline Pakistan Limited.

GlaxoSmithKline Pakistan Limited was incorporated in Pakistan as a limited liability company and is engaged in the manufacturing and marketing of research-based ethical specialities and pharmaceutical products.

The company is a subsidiary of S.R. One International B.V., incorporated in the Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc)

Comments

200 characters remaining